-transparent.png){kind=logo}
Thromboxane B2 (TXB2), along with other primary prostaglandins, was synthesized when rat liver microsomes were incubated with radioactive arachidonic acid. TXB2 was identified directly by chemical ionization mass spectrometry and indirectly by using specific inhibitors of TX synthetase, viz., imidazole and OKY-1555 ((E)-3(4-(3-pyridyl-methyl) phenyl)-2 methyl acrylic acid HCl). The supernatant fraction obtained after centrifugation at 105,000 X g for 60 min contained a possible regulatory component that suppressed thromboxane synthesis. The regulatory influence is lost after partial hepatectomy.
Related Publications
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
October 1978,
European journal of biochemistry,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
December 1978,
Biochimica et biophysica acta,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
January 1980,
Prostaglandins and medicine,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
January 1980,
Advances in prostaglandin and thromboxane research,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
January 1968,
Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
October 1982,
Bioscience reports,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
December 1984,
Prostaglandins, leukotrienes, and medicine,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
January 1971,
Biokhimiia (Moscow, Russia),
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
November 1972,
Proceedings of the National Academy of Sciences of the United States of America,
I Mahmud, and
N Fukui, and
Y Miura, and
H Brandenberger
November 1973,
The Journal of biological chemistry,
